Generic drugs
These companies make and sell generic medicines whose patents have expired, competing on volume and price.
−7.0%
over 1 year · S&P 500 +11.6%
Key indicators
Health
50 / 100
Fragile
Solid
Price
P/E 41
Cheap
Expensive
Up over 1 year
6 of 9
Volatility
33%
Calm
Choppy
Health and price: against the other tags.
Key indicators
When a figure has a bar, the marker places it among its peers, and the further right it sits, the more the figure beats the others. Green marks the best third, red the weakest and white anything in between. Some figures stay white wherever they sit, like price, pace or holding time, because neither side is better there.
The 9 companies
ABT
−14.2%
Size: weight in the tag. Color: move over the period.
See all companies
See all companies
A
Abbott Laboratories
ABT
84.8%
−14.2%
V
Viatris
VTRS
10.5%
+95.9%
A
Amneal Pharmaceuticals
AMRX
3.4%
+79.7%
A
ANI Pharmaceuticals
ANIP
0.7%
−18.1%
A
Amphastar Pharmaceuticals
AMPH
0.6%
+5.5%
N
NRX Pharmaceuticals
NRXP
<0.1%
−17.0%
R
Dr. Reddy's Laboratories
RDY
+7.0%
S
SANDOZ GROUP AG SPONSORED ADS (Switzerland)
SDZNY
+18.1%
T
Teva Pharmaceutical
TEVA
+72.1%